In type 1 endometrial cancer, 92.1% or 91.0% of cases were ER or PR positive, whereas in type 2 endometrial cancer, 71.9% or 64.8% of cases were ER or PR positive respectively (Table 2). The gene discussed is PGR; the disease is endometrial cancer.